| Financial Year |
March 31 2023 |
| Monetary Funds |
73,377,484.55 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
32,584,457.41 |
| Accounts Receivable |
168,383,077.80 |
| Advances to Suppliers |
16,891,767.19 |
| Other Receivables |
20,672,784.44 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
109,032,549.68 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
10,398,283.75 |
| Total Current Assets |
446,345,433.29 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
37,726,511.77 |
| Investment Properties |
-- |
| Fixed Assetes |
237,635,343.84 |
| Under-construction Projects |
6,054,898.26 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
92,531,383.83 |
| R&D expenses |
-- |
| Goodwill |
10,485,974.50 |
| Long-Term Deferred and Prepaid Expenses |
838,804.75 |
| Deferred Income Tax Assets |
28,918,858.91 |
| Other Non-Current Assets |
15,558,778.45 |
| Sub-Total of Non-Current Assets |
455,180,007.52 |
| Total Assets |
901,525,440.81 |
| Short-Term Loans |
104,086,350.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
47,633,426.03 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,142,648.23 |
| Taxes Payable |
20,700,629.81 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
18,581,249.39 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
24,301,770.97 |
| Other Current Liabilities |
22,241,030.92 |
| Sub-Total of Current Liabilities |
278,801,018.71 |
| Long-term Loans |
37,181,352.36 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
49,557,852.50 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
16,747,597.44 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
112,213,239.74 |
| Total Liabilities |
391,014,258.45 |
| Paid-In Capital(Or Share Stock) |
92,807,500.00 |
| Capital Surplus |
249,542,699.53 |
| Surplus Reserve |
15,306,511.25 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
109,371,132.09 |
| Minority Stockholder's Interest |
43,483,339.49 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
467,027,842.87 |
| Owner's Equity（Stockholder's Equity） |
510,511,182.36 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
901,525,440.81 |
